. Author manuscript; available in PMC: 2023 Jan 1.

Published in final edited form as: J Addict Med. 2022 Jan-Feb;16(1):65–71. doi: 10.1097/ADM.0000000000000828

Table 2.

Mortality status and prescription patterns in the final month of follow-up

Characteristic	OUD (n=1,978)	Non-OUD (n=3,224)	Total (n=5,202)
Death status at the end of follow-up, n(%)^***	270 (13.7)	277 (8.6)	547 (10.5)
Prescribed BDZ in the last 30 days, n(%)^***	499 (25.2)	421 (13.1)	920 (17.7)
BDZ dose in the last 30 days (diazepam milligram equivalent per day), mean (SD)^***	1.9 (7.8)	0.6 (3.1)	1.1 (5.4)
Prescribed opioid in the last 30 days, n(%)	1083 (54.8)	1692 (52.5)	2775 (53.3)
Opioid dose in the last 30 days (morphine milligram equivalent per day), mean (SD)^***	19.2 (105.9)	4.0 (29.9)	9.8 (69.8)
Co-prescription of BDZ and opioids, n(%)^***	362 (18.3)	238 (7.4)	600 (11.5)

T-test for continuous variables and chi-square test for categorical variables;

p<.05,

^**

p<.01,

^***

p<.001